Association of blood donor age and sex with recipient survival after red blood cell transfusion

JAMA Internal Medicine

Volumn 176, Issue 9, 2016, Pages 1307-1314

  Chasse, Michael ^a   Tinmouth, Alan ^a,b   English, Shane W ^a,c   Acker, Jason P ^d   Wilson, Kumanan ^a,b   Knoll, Greg ^a,b   Shehata, Nadine ^e   Van Walraven, Carl ^a   Forster, Alan J ^a,b   Ramsay, Timothy ^a   McIntyre, Lauralyn A ^a,b   Fergusson, Dean A ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d CANADIAN BLOOD SERVICES   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD DONOR; CHARLSON COMORBIDITY INDEX; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; RECIPIENT; SEX DIFFERENCE; TRANSFUSION RECIPIENT; TREATMENT OUTCOME; VERY ELDERLY; CANADA; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; EPIDEMIOLOGY; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BLOOD DONORS; CANADA; COHORT STUDIES; COMORBIDITY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODELS; SEX FACTORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84999027808     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2016.3324     Document Type: Article

References (47)

1. Pfuntner A, Wier LM, Stocks C. Most Frequent Procedures Performed in US Hospitals, 2011: Statistical Brief #165. Rockville, MD: Agency for Health Care Policy and Research; 2006-2013. Healthcare Cost and Utilization Project Statistical Briefs.
2. Wang JK, Klein HG. Red blood cell transfusion in the treatment and management of anaemia: the search for the elusive transfusion trigger. Vox Sang. 2010;98(1):2-11.
3. Raghavan M, Marik PE. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest. 2005;127(1):295-307.
4. Bennett-Guerrero E, Zhao Y, O'Brien SM, et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA. 2010;304(14): 1568-1575.
5. Carson JL, Grossman BJ, Kleinman S, et al; Clinical Transfusion Medicine Committee of the AABB. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012; 157(1):49-58.
6. Vamvakas EC, Blajchman MA. Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality. Transfus Med Rev. 2010;24(2):77-124.
7. Price EA. Aging and erythropoiesis: current state of knowledge. Blood Cells Mol Dis. 2008;41(2):158-165.
8. Balducci L, Hardy CL. Anemia of aging: a model of erythropoiesis in cancer patients. Cancer Control. 1998;5(2)(suppl 1):17-21.
9. Henry CJ, Marusyk A, DeGregori J. Aging-associated changes in hematopoiesis and leukemogenesis: what's the connection? Aging (Albany NY). 2011;3(6):643-656.
10. Caprari P, Scuteri A, Salvati AM, et al. Aging and red blood cell membrane: a study of centenarians. Exp Gerontol. 1999;34(1):47-57.
11. Toy P, Gajic O, Bacchetti P, et al; TRALI Study Group. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012;119(7):1757-1767.
12. Lin Y, Saw CL, Hannach B, Goldman M. Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services. Transfusion. 2012;52(3):567-574.
13. Chassé M, McIntyre L, Tinmouth A, et al. Clinical effects of blood donor characteristics in transfusion recipients: protocol of a framework to study the blood donor-recipient continuum. BMJ Open. 2015; 5(1):e007412. doi:10.1136/bmjopen-2014-007412.
14. Taylor DO, Stehlik J, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report: 2009. J Heart Lung Transplant. 2009;28(10):1007-1022.
15. Bonser RS, Taylor R, Collett D, Thomas HL, Dark JH, Neuberger J; Cardiothoracic Advisory Group to NHS Blood and Transplant and the Association of Lung Transplant Physicians (UK). Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry. Lancet. 2012;380(9843):747-755.
16. Bittle GJ, Sanchez PG, Kon ZN, et al. The use of lung donors older than 55 years: a review of the United Network of Organ Sharing database. J Heart Lung Transplant. 2013;32(8):760-768.
17. Lee KW, Simpkins CE, Montgomery RA, Locke JE, Segev DL, Maley WR. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation. 2006; 82(12):1683-1688.
18. Rayhill SC, Wu YM, Katz DA, et al. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. Transplantation. 2007;84(3):331-339.
19. Akkina SK, Asrani SK, Peng Y, Stock P, Kim WR, Israni AK. Development of organ-specific donor risk indices. Liver Transpl. 2012;18(4):395-404.
20. Maglione M, Ploeg RJ, Friend PJ. Donor risk factors, retrieval technique, preservation and ischemia/reperfusion injury in pancreas transplantation. Curr Opin Organ Transplant. 2013; 18(1):83-88.
21. Kollman C, Howe CW, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001;98(7): 2043-2051.
22. Schultz KR, Green GJ, Wensley D, et al. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood. 1994;84(9): 3212-3220.
23. Middelburg RA, Briët E, van der Bom JG. Mortality after transfusions: relation to donor sex. Vox Sang. 2011;101(3):221-229.
24. Chassé M, McIntyre L, English SW, et al. Effect of blood donor characteristics on transfusion outcomes: a systematic review and meta-analysis. Transfus Med Rev. 2016;30(2):69-80.
25. National Heart, Lung, and Blood Institute. State of the Science in Transfusion Medicine; March 25-26, 2015; Bethesda, MD. http://www.nhlbi.nih.gov/research/reports/2015-state-science-transfusion-medicine-sos. Published 2015. Accessed December2, 2015.
26. Needham DM, Scales DC, Laupacis A, Pronovost PJ. A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care. 2005;20(1):12-19.
27. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57(12): 1288-1294.
28. Sharabiani MT, Aylin P, Bottle A. Systematic review of comorbidity indices for administrative data. Med Care. 2012;50(12):1109-1118.
29. Heddle NM, Eikelboom J, Liu Y, Barty R, Cook RJ. Exploratory studies on the age of transfused blood and in-hospital mortality in patients with cardiovascular diagnoses. Transfusion. 2015;55(2): 364-372.
30. Andersen P, Gill R. Cox's regression model for counting processes: a large sample study. Ann Stat. 1982;10(4):1100-1120.
31. Hayati Rezvan P, Lee KJ, Simpson JA. The rise of multiple imputation: a review of the reporting and implementation of the method in medical research. BMC Med Res Methodol. 2015;15:30.
32. World Health Organization. 10 Facts on blood transfusion. http://www.who.int/features/factfiles/blood-transfusion/en/. Reviewed June 2015. Accessed April 14, 2016.
33. Villeda SA, Plambeck KE, Middeldorp J, et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat Med. 2014;20(6):659-663.
34. Loffredo FS, Steinhauser ML, Jay SM, et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013;153(4):828-839.
35. Nowlis E, Nathens AB, Konkle B, Dinwiddie S, Watkins TR. The effect of red blood cell donor age on lung injury development after hemorrhagic trauma. Transfusion. 2012;52:171A-172A.
36. Porretti L, Cattaneo A, Coluccio E, et al. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors. Blood Transfus. 2012;10(3):351-359.
37. Gajic O, Yilmaz M, Iscimen R, et al. Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components. Crit Care Med. 2007;35(7):1645-1648.
38. Petersen LR, Satten GA, Dodd R, et al; HIV Seroconversion Study Group. Duration of time from onset of human immunodeficiencyvirus type 1 infectiousness to development of detectable antibody. Transfusion. 1994;34(4):283-289.
39. Manns A, Wilks RJ, Murphy EL, et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer. 1992;51(6):886-891.
40. Vasan SK, Chiesa F, Rostgaard K, et al. Lack of association between blood donor age and survival of transfused patients. Blood. 2016;127(5):658-661.
41. Atsma F, Veldhuizen I, Verbeek A, de Kort W, de Vegt F. Healthy donor effect: its magnitude in health research among blood donors. Transfusion. 2011;51(8):1820-1828.
42. Hilário S, Saldanha C, Martins e Silva J. An in vitro study of adrenaline effect on human erythrocyte properties in both gender. Clin Hemorheol Microcirc. 2003;28(2):89-98.
43. Murphy WG. The sex difference in haemoglobin levels in adults: mechanisms, causes, and consequences. Blood Rev. 2014;28(2):41-47.
44. Twomley KM, Rao SV, Becker RC. Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions. J Thromb Thrombolysis. 2006;21 (2):167-174.
45. Buddeberg F, Schimmer BB, Spahn DR. Transfusion-transmissible infections and transfusion-related immunomodulation. Best Pract Res Clin Anaesthesiol. 2008;22(3):503-517.
46. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352(9128):609-613.
47. Wood L, Egger M, Gluud LL, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 2008; 336(7644):601-605.